1829 - Dalbavancin versus standard of care as directed therapy for Staphylococcus aureus bacteremia in patients unable to receive OPAT

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Co-Author(s)

JF

J Frazier, Pharm.D., MBA

Phoebe Putney Memorial Hospital
Moultrie, Georgia, United States
LS

Laura Stoudenmire, PharmD

Phoebe Putney Memorial Hospital
Albany, Georgia, United States
JW

Jamie Wagner, PharmD

Clinical Assistant Professor
University of Mississippi School of Pharmacy
Jackson, Mississippi, United States
GT

Geren Thomas, Pharm.D. BCPS

Clinical Pharmacist
John D. Archbold Memorial Hospital
Thomasville, Georgia, United States
AH

Andrés F. Henao-Martínez, MD

University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Carlos Franco-Paredes, MD, MPH

Associate Professor, Program Director of ID Fellowship
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States

Daniel B. Chastain, Pharm.D., BCIDP, AAHIVP

Clinical Associate Professor
University of Georgia College of Pharmacy
Albany, Georgia, United States